PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Regions Hospital, Health Partners, St. Paul, MN, USA.\', \'Houston Methodist Hospital, Houston, TX, USA.\', \'Department of Emergency Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.\', \'MemorialCare Long Beach Medical Center, Long Beach, CA, USA.\', \'Aurora BayCare Medical Center, Green Bay, WI, USA.\', \'Henry Ford Hospital System, Detroit, MI, USA.\', \'Princeton Pharmatech, Princeton, NJ, USA.\', \'CalciMedica, Inc, 505 Coast Blvd. South Suite 307, La Jolla, CA, 92037, USA.\', \'CalciMedica, Inc, 505 Coast Blvd. South Suite 307, La Jolla, CA, 92037, USA. sudarshan@calcimedica.com.\', \'Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13054-022-03964-8
?:doi
?:hasPublicationType
?:journal
  • Critical care (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 35395943
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35395943>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35395943>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all